A
Arnon Nagler
Researcher at Sheba Medical Center
Publications - 1435
Citations - 51740
Arnon Nagler is an academic researcher from Sheba Medical Center. The author has contributed to research in topics: Transplantation & Hematopoietic stem cell transplantation. The author has an hindex of 98, co-authored 1316 publications receiving 44298 citations. Previous affiliations of Arnon Nagler include French Institute of Health and Medical Research & University of Paris.
Papers
More filters
Journal ArticleDOI
Sorafenib improves survival of FLT3-mutated acute myeloid leukemia in relapse after allogeneic stem cell transplantation: a report of the EBMT Acute Leukemia Working Party.
Ali Bazarbachi,Myriam Labopin,Giorgia Battipaglia,Azedine Djabali,Jakob Passweg,Gérard Socié,Edouard Forcade,Didier Blaise,Patrice Chevallier,Corentin Orvain,Jan J. Cornelissen,William Arcese,Sylvain Chantepie,Khowla Hashaishi,Jean El Cheikh,Michael Medinger,Jordi Esteve,Arnon Nagler,Mohamad Mohty +18 more
TL;DR: The prognosis of acute myeloid leukemia (AML) with FMS-like tyrosine kinase 3 internal tandem duplication ( FLT3-ITD) is generally poor and patients are referred to allogeneic stem cell transplantation in first complete remission (CR).
Journal ArticleDOI
High CD3+ and CD34+ peripheral blood stem cell grafts content is associated with increased risk of graft-versus-host disease without beneficial effect on disease control after reduced- intensity conditioning allogeneic transplantation from matched unrelated donors for acute myeloid leukemia - an analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Tomasz Czerw,Myriam Labopin,Christoph Schmid,Jan J. Cornelissen,Patrice Chevallier,Didier Blaise,J. Kuball,Stephane Vigouroux,Frédéric Garban,Bruno Lioure,Nathalie Fegueux,Laurence Clement,Anna Sandstedt,Johan Maertens,Gaelle Guillerm,Dominique Bordessoule,Mohamad Mohty,Mohamad Mohty,Arnon Nagler +18 more
TL;DR: In this article, the impact of graft composition on the incidence of graft versus host disease (GVHD), disease control and survival after reduced-intensity conditioning (RIC) allogeneic peripheral blood stem cell transplantation (allo-PBSCT) was analyzed.
Journal Article
Effects of CSFs in preleukemia.
TL;DR: Based on pre-clinical and in vitro studies demonstrating enhanced granulocytic proliferation and differentiation induced by granulocytes-monocyte and granulocyte-colony stimulating factors, these recombinant human hormones have been used to treat cytopenic patients with preleukemia and four of the 18 individuals have subsequently developed AML after 6-16 months.
Journal ArticleDOI
The CXCR4 antagonist 4F-benzoyl-TN14003 stimulates the recovery of the bone marrow after transplantation.
Michal Abraham,Katia Beider,Hanna Wald,Ido D. Weiss,Dov Zipori,Eithan Galun,Arnon Nagler,O. Eizenberg,Peled A +8 more
TL;DR: The unique ability of the CXCR4 antagonist, T140 to stimulate the production and exit of WBC cells may be used as a novel therapeutic approach to overcome cytopenia associated with treatments for cancer and BM transplantation.
Journal ArticleDOI
New developments in bone marrow transplantation.
Shimon Slavin,Arnon Nagler +1 more
TL;DR: The data suggest that eradication of the last tumor cell is neither feasible nor necessary for achieving operational cure, and control of minimal residual disease by activation of anticancer effector cells today seems closer than ever.